Zoar Limited Company Profile
NYSE: ZOARHealthcareDrug Manufacturers - GeneralUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Zoar at a glance
Zoar Limited (NYSE: ZOAR) is a Drug Manufacturers - General company in the Healthcare sector headquartered in Hung Hom, Hong Kong. The company's shares have traded publicly since 2026. At a market capitalization of $608.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002078148, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Zoar do?
Zoar Limited, a pharmaceutical company, engages in the development, manufacturing, and distribution of pharmaceutical ingredients (APIs) and intermediates in Africa, the Middle East, India, Central and South America, Asia, and Europe. The company offers APIs for anti-cancer, respiratory diseases, malaria, and cardiovascular health; and orphan drugs for rare diseases. It also provides drug contract development and manufacturing services to pharmaceutical companies. The company was founded in 2012 and is headquartered in Hung Hom, Hong Kong.
Business description based on the company's public filings.
Company information
- Legal name
- Zoar Limited
- Ticker
- NYSE: ZOAR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Headquarters
- 1504, Peninsula Square, Hung Hom, Hong Kong
- Phone
- 345-749-8307
- Website
- zoarlimited.com
- IPO year
- 2026
- Market cap
- $608.40M
- SEC CIK
- 0002078148